In the present study, we found that CEA, AST and D-dimer were independently related to the ORR after neoadjuvant immunotherapy, indicating that these laboratory indicators before neoadjuvant therapy played an important role in predicting ORR of patients with esophageal cancer. The gene discussed is CEACAM5; the disease is esophageal cancer.